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Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) has been a global health concern since December 2019. It
was feared that intermittent positive cases may indicate a
reinfection as there were a number of patients who had pos-
itive reverse-transcriptaseepolymerase-chain-reaction (RT-
PCR) after an initial negative test [1]. The diagnosis of COVID-
19 is based on detection of SARS-CoV-2 by real-time RT-PCR
assay [2]. The sensitivity of RT-PCR is low in the early course of
the disease, ranging between 45 and 60%, and thus may require
more testing to reach a diagnosis [3]. Hospitalized COVID-19
patients had a median duration for viral conversion of 20
days after onset of symptoms [4]. One study showed that the
median duration from onset of symptoms to negative RT-PCR
was 24 days (interquartile range (IQR), 18e31 days) [5]. At
weeks 4 and 5, the rates of positive RT-PCR were 32.1% and
5.4%, respectively [5]. Here, we describe the occurrence of
intermittent positive PCR and the duration of viral PCR pos-
itivity in patients with SARS-CoV-2 infection in patients
admitted to Qatif Central Hospital, Saudi Arabia.
The study included adult (>14 years of age) hospitalized
patients with confirmed SARS-COV-2 infection from 1st March
2020 to 8th May 2020 who underwent multiple SARS-CoV-2 tests
of respiratory tract samples, mainly nasopharyngeal swabs, by
RT-PCR. Laboratory diagnosis relied on repeat testing after 48 h
if patients became asymptomatic and had no documented
fever for more than 3 days; and then repeat testing was done
every fifth day if the initial test was positive. For removal from
isolation, patients were required to have two negative con-
secutive tests 24 h apart with clinical improvement or
stabilization.
The respiratory samples were tested using RT-PCR amplifi-
cation targeting the upstream E gene and S gene. The test was
based on the RealStar SARS-CoV-2 RT-PCR Kit 1.0 (Altona
Diagnostics, Hamburg, Germany). The study was approved byhttps://doi.org/10.1016/j.jhin.2020.09.011
0195-6701/ª 2020 The Healthcare Infection Society. Published by Elsevierthe institutional research ethics committee of Qatif Central
Hospital (QCH), Eastern Province, Saudi Arabia
(4271T8361000). Positive test was defined as positivity for E
and S genes; negative test was defined as negative E and S
genes; and possible test was defined as negative E but positive
S genes. During the study period, there were 82 confirmed
COVID-19 patients and of those 42 (51%) had intermittent
positive PCR tests (Figure 1). Of those with intermittent pos-
itive tests, 24 (57%) had eventually two consecutive negative
tests and were cleared. The mean and median days to clear-
ance were 28.9 and 31 days, respectively. In addition, 90% of
patients had negative samples at day 40 from the first positive
swab.
There are possible explanations for the appearance of
positive tests after negative tests. These explanations
include: initial false negative tests due to the presence of PCR
reaction inhibitors or due to the sampling methodology, the
first sample being below the level of detection, or false-
positive tests. Previous WHO recommendations called for
the discharge of COVID-19 patients after clearance of infec-
tion based on two negative RT-PCR results on sequential
samples taken at least 24 h apart. However, these criteria
were changed to a time-based strategy which is 10 days from
the first positive sample, provided that the patient had no
symptoms for at least 3 days.
Here, we observed that 51% had recurrence of a positive PCR
after a negative test. In a previous study, 14.5% of COVID-19
patients had positive RT-PCR testing following discharge [6].
Similarly, in a study of 209 discharged patients 10.5% had
appearance of positive PCR after initial negative tests 4.7 days
after discharge [7]. Moreover, in a study of 70 COVID-19
patients, 21.4% re-tested positive after two consecutive neg-
ative PCR tests [8]. That study showed no difference in age,
severity of illness or gender between those who had inter-
mittent positive and those who did not [8].
In this study, the mean and median days to negative in those
with intermittent positive was 28.9 and 31 days, respectively.
Similarly, a previous study of such patients found that median
time was 36 (28e40) days [8]. Kinetics of viral load in 12
severely ill COVID-19 patients requiring mechanical ventilation
and 11 mild COVID-19 patients showed that viral shedding las-
ted about 10 days in most of the mild patients and 20e40 days
in most severely affected patients [9].
In conclusion, we observed intermittent positive PCR tests
for SARS-CoV-2. The study however did not address the via-
bility of the virus as we did not have viral cultures. TheLtd. All rights reserved.
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27 (+) (+) (-) (+) (-)
28 (+) (+) (+) (+) (-) (+) (-)
29 (+) (+) (+) (-) (-) (+) (-) (+) (-) (-)
30 (+) (+) (+) (+) (+) (-) (+) (-)
31 (+) (+) (-) (+) (-) (-)
32 (+) (+) (+) (+) (+) (-) (+) (+) (-) (+) (-)
33 (+) (+) (+) (+) (-) (+) (-) (+) (-)
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37 (+) (+) (-) (?) (-) (+) (-) (-)
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40 (?) (+) (-) (+) (+) (-) (+) (-)
41 (+) (+) (-) (+) (+) (+) (-) (-)
42 (?) (+) (+) (+) (+) (-) (+) (+)  
Figure 1. The course of patients with intermittent positive SARS-CoV-2 polymerase chain reaction (PCR). Each patient is represented by a
row and the columns represent the number of PCR tests since the initial encounter. Red indicates positive (þ) tests; yellow possible (?)
tests, and green negative (-) tests.
Letter to the Editor / Journal of Hospital Infection 107 (2021) 98e100 99persistence of SARS-CoV-2 and the development of inter-
mittent positive tests may merely indicate the detection of
viral RNA. The prolonged shedding of the virus is not an indi-
cation of continued infection without viral cultures. It is also
important to understand viral dynamics in other tissues such
as urine, blood and others.Author contributions
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